1. Home
  2. PACK vs ABEO Comparison

PACK vs ABEO Comparison

Compare PACK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACK
  • ABEO
  • Stock Information
  • Founded
  • PACK 1972
  • ABEO 1974
  • Country
  • PACK United States
  • ABEO United States
  • Employees
  • PACK N/A
  • ABEO N/A
  • Industry
  • PACK Containers/Packaging
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PACK Consumer Discretionary
  • ABEO Health Care
  • Exchange
  • PACK Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • PACK 313.3M
  • ABEO 332.0M
  • IPO Year
  • PACK N/A
  • ABEO 1980
  • Fundamental
  • Price
  • PACK $5.29
  • ABEO $6.83
  • Analyst Decision
  • PACK Buy
  • ABEO Strong Buy
  • Analyst Count
  • PACK 3
  • ABEO 6
  • Target Price
  • PACK $7.17
  • ABEO $18.17
  • AVG Volume (30 Days)
  • PACK 1.3M
  • ABEO 702.3K
  • Earning Date
  • PACK 08-05-2025
  • ABEO 08-14-2025
  • Dividend Yield
  • PACK N/A
  • ABEO N/A
  • EPS Growth
  • PACK N/A
  • ABEO N/A
  • EPS
  • PACK N/A
  • ABEO 0.99
  • Revenue
  • PACK $380,700,000.00
  • ABEO $400,000.00
  • Revenue This Year
  • PACK $10.14
  • ABEO N/A
  • Revenue Next Year
  • PACK $7.92
  • ABEO $339.63
  • P/E Ratio
  • PACK N/A
  • ABEO $6.91
  • Revenue Growth
  • PACK 10.38
  • ABEO N/A
  • 52 Week Low
  • PACK $2.91
  • ABEO $3.93
  • 52 Week High
  • PACK $8.70
  • ABEO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • PACK 67.12
  • ABEO 52.71
  • Support Level
  • PACK $5.02
  • ABEO $6.70
  • Resistance Level
  • PACK $6.31
  • ABEO $7.15
  • Average True Range (ATR)
  • PACK 0.33
  • ABEO 0.31
  • MACD
  • PACK 0.10
  • ABEO -0.02
  • Stochastic Oscillator
  • PACK 55.24
  • ABEO 46.62

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: